HAMMOND SURGICAL LLC — History
CCN 190303 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$35M
Latest Revenue (FY2022)
+14.9%
Revenue CAGR (3yr)
-1.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $27M | $32M | $35M | +9.3% | +14.9% |
| Operating Expenses | $31M | $35M | $36M | +3.9% | +8.4% |
| Operating Margin | -14.4% | -7.0% | -1.8% | +75.0% | +0.0% |
| Net Income | $-4M | $-2M | $-1M | +72.7% | +0.0% |
| Licensed Beds | 30 | 30 | 30 | +0.0% | +0.0% |
| Total Patient Days | 1,078 | 1,125 | 1,057 | -6.0% | -1.0% |
| Medicare Day % | 32% | 24% | 27% | +13.5% | -6.9% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +32.1% ($27M → $35M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+14.9%
This Hospital
+7.6%
State Avg
Latest Margin
-1.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $40M | 4.6% |
| FY2024 (proj) | $44M | 10.9% |
| FY2025 (proj) | $48M | 17.2% |